F1000Research 2019, 8:323 Last updated: 17 MAY 2019
PLOS ONE | https://doi.org/10.1371/journal.pone.0185526 September 28, 2017
Global Health and Tropical Medicine, GHTM, Instituto de Higiene e Medicina Tropical, IHMT, Universidade Nova de Lisboa, UNL, Lisboa, Portugal
front cover © Hannah Maule-Ffinch/Save the Children
ICAAP12 Secretariat
Partners in population and development, Dhaka, Bangladesh June 2016
BMJ,Dodd PJ, et al. Thorax 2017;72:559–575. doi:10.1136/thoraxjnl-2016-209421
Kyiv, Ukraine 22-24 November 2010
Meeting Report
Towards the Peoples Health Assembly Book -2
Anxiety Disorders
Chapter F.4
Djibuti et al. BMC Public Health (2015) 15:427 DOI 10.1186/s12889-015-1760-z
This technical report presents results from the FEEDcities Project – eastern Europe and central Asia. This cross-sectional survey was conducted in Ashgabat, Turkmenistan in October 2016 to evaluate the local urban food environment. It characterized the vending sites, the food offered and the nutri...tional composition of the industrial and homemade street foods available in these settings. It also described the nutritional composition of ready-to-eat foods sold in supermarkets and at vending sites in food courts. The policy implications of the findings are outlined.
more
The United Nations Secretary-General, António Guterres, echoed the concerns of people and organisations around the world when he recently referred to the impact of the COVID-19 pandemic on schooling as a
‘generational catastrophe’.
.
22 Sept. 2021
The rapid development of effective Covid-19 vaccines in 2020 gave hope to the world in the darkest days of the deadly pandemic. However, the vaccine roll-out has been massively skewed towards wealthy nations. While rich states have hoarded vaccines, companies have also played a decisi...ve role in restricting fair access to a life-saving health product. This report focuses on six leading vaccine developers, AstraZeneca, BioNTech, Johnson & Johnson, Moderna, Novavax and Pfizer, assessing each company’s human rights policy, pricing structure, records on intellectual property, knowledge and technology sharing, allocation of available vaccine doses and transparency.
Available in Arabic, English, French, German and Spanish
more